Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 8,488 | 5,392 | 6,215 | 4,218 | 5,820 |
| Operating Income | -8,488 | -5,392 | -6,215 | -4,218 | -5,820 |
| Other Income | 172 | 227 | 307 | 388 | 377 |
| Pre-tax Income | -8,316 | -5,165 | -5,908 | -3,830 | -5,443 |
| Income Tax | N/A | N/A | -424 | -527 | -359 |
| Net Income Continuous | -8,316 | -5,165 | -5,484 | -3,303 | -5,084 |
| Net Income | $-8,316 | $-5,165 | $-5,484 | $-3,303 | $-5,084 |
| EPS Basic Total Ops | -10.72 | -7.53 | -7.63 | -4.85 | -8.50 |
| EPS Basic Continuous Ops | -10.72 | -7.53 | -7.85 | -4.85 | -8.38 |
| EPS Diluted Total Ops | -10.72 | -7.53 | -7.63 | -4.85 | -8.50 |
| EPS Diluted Continuous Ops | -10.72 | -7.53 | -7.85 | -4.85 | -8.38 |
| EPS Diluted Before Non-Recurring Items | -5.50 | -7.50 | -8.00 | N/A | N/A |
| EBITDA(a) | $-4,382 | $-5,353 | $-6,176 | $-4,186 | $-5,788 |